Venz, Richard
Goyala, Anita
Soto-Gamez, Abel
Yenice, Tugce
Demaria, Marco
Ewald, Collin Y. http://orcid.org/0000-0003-1166-4171
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (190072)
Swiss Federal Institute of Technology Zurich
Article History
Received: 15 March 2023
Accepted: 7 August 2023
First Online: 29 August 2023
Declarations
:
: The authors have no competing interests to declare. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. CYE is a co-founder and shareholder of Avea Life AG, and is on the Scientific Advisory Board of Maximon AG, Biotein, Longaevus Technologies LTD, and Galyan Bio, INC. Correspondence should be addressed to C. Y. E.